The initiative, dubbed “Being Human,” will include exhibits, a digital series, and other events that aim to “examine the ...

WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA – a genetically validated target that provides a new approach for healthy, ...

Near-Earth asteroid Bennu has a slim chance of colliding with Earth in 2182. If it does, the impact could trigger a global ...

The National Institutes of Health, the nation’s premier funder of biomedical research, announced Friday that it will ...

In addition, the MediWound management team will host one-on-one meetings during the conference. Interested investors are encouraged to contact their Oppenheimer representative to schedule a meeting.

SAN DIEGO, Feb. 3, 2025 /PRNewswire/ -- Breakthrough Properties ("Breakthrough"), a leading global life science real estate developer, owner and operator, today announced the acquisition of MUSE ...

APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics and headquartered in Switzerland, ...

YAVNE, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE ... chat during the upcoming Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual). The fireside chat, hosted by Francois Brisebois ...

France’s AI Action Summit marks a departure from previous gatherings. Some welcome the change. Others say safety has been ...

global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab's management team will participate in Oppenheimer's 35 th ...

This latest initiative raises Hitachi’s total investment in CVC to $1 billion, reinforcing its commitment to identifying and ...